Basic Qualifications We are looking for professionals with these required skills to achieve our goals: Medical degree with board certification/eligibility or registration qualifications in medical oncology, hematology or hematology/oncology Experience in the pharmaceutical/biotechnology industry, clinical academic medicine, or clinical medical practice, in the field of hematology and/or oncology Oncology clinical drug development experience in the conduct of clinical trials (investigator-initiated, company-sponsored or cooperative group trials) and their subsequent publications Preferred Qualifications If you have the following characteristics, it would be a plus: MD / PhD preferred Clinical experience of managing patients with hematological malignancies Oncology clinical research and drug development experience focused on hematological malignancies, including multiple myeloma Sound understanding of biological mechanisms, clinical strategy, scientific interpretation of disease and target-based literature Robust knowledge of preclinical/ mechanistic translational research, disease-specific research priorities, competitor landscape, and treatment guidelines evolution • If you are based in Cambridge, MA; Waltham, MA; Rockville, MD; or San Francisco, CA, the annual base salary for new hires in this position ranges $222,750 to $371,250. Key Responsibilities Collaborate with physicians, scientists, regulatory professionals, biostatisticians, executive staff, and others in a complex matrix environment to develop and execute phase 1-3 interventional clinical trials Use medical expertise to contribute to the end-to-end (protocol concept to final study report) and timely delivery of clinical trials while ensuring patient safety, scientific integrity, and consistency with the clinical development strategy; demonstrate ability to incorporate global considerations into decision making Ensure high-quality protocol development aligned with the early Clinical Development Plan to effectively determine a medicine's potential efficacy, safety profile, key areas of product differentiation and value to patient in the shortest possible timeframe.